Preprint
Adverse effects of remdesivir, hydroxychloroquine, and lopinavir/ritonavir when used for COVID-19: systematic review and meta-analysis of randomized trials
Abstract
Abstract Introduction In an attempt to improve outcomes for patients with coronavirus disease 19 (COVID-19), several drugs, such as remdesivir, hydroxychloroquine (with or without azithromycin), and lopinavir/ritonavir, have been evaluated for treatment. While much attention focuses on potential benefits of these drugs, this must be weighed against their adverse effects. Methods We searched 32 databases in multiple languages from 1 December …
Authors
Izcovich A; Siemieniuk RA; Bartoszko JJ; Ge L; Zeraatkar D; Kum E; Khamis AM; Rochwerg B; Agoritsas T; Chu DK
DOI
10.1101/2020.11.16.20232876
Preprint server
medRxiv